Tesamorelin is a synthetic analog of growth hormone-releasing hormone (GHRH) extensively studied in laboratory settings for its potential roles in stimulating endogenous growth hormone production. Laboratory research involving Tesamorelin explores its effects on lipolysis, metabolic regulation, and body composition changes. Studies indicate Tesamorelin may impact abdominal fat reduction and metabolic health through growth hormone secretion pathways.
Scientific investigations continue to explore Tesamorelin’s potential impacts on fat metabolism, muscle composition, and growth hormone-related metabolic processes within controlled laboratory environments.
Important Notice: This product is intended strictly for research purposes only. It is not approved by the FDA and is not intended for human or animal consumption, nor for diagnostic, therapeutic, or clinical applications. Usage of Tesamorelin outside laboratory research settings violates sections 505(a) and 301(d) of the Federal Food, Drug, and Cosmetic Act (FD&C Act), 21 U.S.C. §§ 355(a) and 331(d).
Product Specifications:
- Purity: ≥99% (HPLC verified)
- Formulation: Lyophilized powder
- Molecular Formula: C211H366N72O67S
- Molecular Weight: 5135.89 g/mol
- CAS Number: 218949-48-5
Source: PubChem